Cargando…
Expression Characteristics and Clinical Correlations of BRD1 in Colorectal Cancer Samples
The incidence of colorectal cancer (CRC), as well as subsequent patient mortality, has increased in the last decade; an unhealthy diet is considered to be the leading cause. Previous studies have shown the potential of the bromodomain containing 1 (BRD1) gene as a therapeutic target for CRC based on...
Autores principales: | Li, Zhou, Wang, Junjie, Ji, Yuzhu, Song, Fangzhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422826/ https://www.ncbi.nlm.nih.gov/pubmed/34482774 http://dx.doi.org/10.1177/15330338211039678 |
Ejemplares similares
-
BRD4 Inhibitor Inhibits Colorectal Cancer Growth and Metastasis
por: Hu, Yuan, et al.
Publicado: (2015) -
Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion
por: Liu, Yi, et al.
Publicado: (2023) -
tBRD-1 and tBRD-2 regulate expression of genes necessary for spermatid differentiation
por: Theofel, Ina, et al.
Publicado: (2017) -
Preparation data of the bromodomains BRD3(1), BRD3(2), BRD4(1), and BRPF1B and crystallization of BRD4(1)-inhibitor complexes
por: Hügle, Martin, et al.
Publicado: (2016) -
Targeting bromodomain-containing protein 4 (BRD4) inhibits MYC expression in colorectal cancer cells
por: Otto, C., et al.
Publicado: (2019)